T. Parry

430 total citations
7 papers, 124 citations indexed

About

T. Parry is a scholar working on Molecular Biology, Oncology and Spectroscopy. According to data from OpenAlex, T. Parry has authored 7 papers receiving a total of 124 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Spectroscopy. Recurrent topics in T. Parry's work include Cancer, Lipids, and Metabolism (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Chemical Synthesis and Analysis (1 paper). T. Parry is often cited by papers focused on Cancer, Lipids, and Metabolism (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Chemical Synthesis and Analysis (1 paper). T. Parry collaborates with scholars based in United Kingdom, Ukraine and United States. T. Parry's co-authors include P. D. McCormack, James Carmichael, Jānis Gardovskis, J. Michael Dixon, Nigel Bundred, J. Eglītis, Janusz Jaśkiewicz, Helen Swaisland, Christopher J. Smith and Ian D. Wilson and has published in prestigious journals such as Journal of Clinical Oncology, Analytical Chemistry and Xenobiotica.

In The Last Decade

T. Parry

6 papers receiving 119 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Parry United Kingdom 4 84 55 18 15 13 7 124
Elizabeth A. Pilling United Kingdom 6 86 1.0× 65 1.2× 3 0.2× 9 0.6× 13 1.0× 8 177
Dilana E. Staudt Australia 7 47 0.6× 63 1.1× 5 0.3× 9 0.6× 44 3.4× 8 200
Aad I. de Vos Netherlands 4 120 1.4× 30 0.5× 3 0.2× 5 0.3× 34 2.6× 5 177
Xinran Ma China 6 45 0.5× 18 0.3× 8 0.4× 4 0.3× 7 0.5× 17 111
Priscilla Carter United States 9 19 0.2× 71 1.3× 15 0.8× 25 1.7× 41 3.2× 13 238
Aileen Marshall United States 6 75 0.9× 103 1.9× 8 0.5× 10 0.8× 6 200
Forough Abbasi United States 7 46 0.5× 114 2.1× 3 0.2× 2 0.1× 9 0.7× 15 173
Pascal Martel France 6 32 0.4× 46 0.8× 12 0.7× 7 0.5× 1 0.1× 7 131
Hildegunn Helle Norway 7 140 1.7× 87 1.6× 5 0.3× 16 1.1× 242 18.6× 9 323
Michael P. Woods United States 7 23 0.3× 171 3.1× 10 0.6× 41 2.7× 15 1.2× 9 316

Countries citing papers authored by T. Parry

Since Specialization
Citations

This map shows the geographic impact of T. Parry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Parry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Parry more than expected).

Fields of papers citing papers by T. Parry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Parry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Parry. The network helps show where T. Parry may publish in the future.

Co-authorship network of co-authors of T. Parry

This figure shows the co-authorship network connecting the top 25 collaborators of T. Parry. A scholar is included among the top collaborators of T. Parry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Parry. T. Parry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Collins, S.M., J. M. Daugas, U. Köster, et al.. (2025). Towards complete decay spectroscopy of 152Tb. Radiation Physics and Chemistry. 232. 112641–112641.
2.
Yu, Hong, Nigel Barrass, Eva M. Lenz, et al.. (2014). Metabolism by conjugation appears to confer resistance to paracetamol (acetaminophen) hepatotoxicity in the cynomolgus monkey. Xenobiotica. 45(3). 270–277. 11 indexed citations
3.
Bundred, Nigel, Jānis Gardovskis, Janusz Jaśkiewicz, et al.. (2013). Evaluation of the pharmacodynamics and pharmacokinetics of the PARP inhibitor olaparib: a Phase I multicentre trial in patients scheduled for elective breast cancer surgery. Investigational New Drugs. 31(4). 949–958. 71 indexed citations
4.
McCormack, P. D., M. Macpherson, David M. Wilson, et al.. (2004). Pharmacokinetic characterization of the novel oral prenyl transferase inhibitor AZD3409: The first analysis in healthy male volunteers. Journal of Clinical Oncology. 22(14_suppl). 3172–3172. 3 indexed citations
5.
McCormack, P. D., et al.. (2004). Pharmacokinetic characterization of the novel oral prenyl transferase inhibitor AZD3409: The first analysis in healthy male volunteers. Journal of Clinical Oncology. 22(14_suppl). 3172–3172. 6 indexed citations
6.
Smethurst, Dominic, et al.. (2004). Tolerability results from the first study of the novel oral prenyl transferase inhibitor AZD3409 in human volunteers. Journal of Clinical Oncology. 22(14_suppl). 3177–3177. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026